Biotech

Moderna Inc.‘s (NASDAQ:MRNA) stock has staged a dramatic comeback this week, adding billions in market value and delivering a windfall for investors in a leveraged ETF tied to the biotech company as traders bet on a favorable regulatory outcome for its seasonal flu vaccine. Shares of Moderna...

HCW Biologics Inc. (NASDAQ:HCWB) surged on Friday after reporting stronger quarterly results and highlighting progress across its autoimmune pipeline. Investor sentiment also improved after the biotech company advanced a licensing deal and reaffirmed upcoming clinical data milestones, sending the...

SELLAS Life Sciences Group Inc. (NASDAQ:SLS) reported first-quarter (Q1) 2026 financial results on Tuesday while highlighting progress across its acute myeloid leukemia (AML) pipeline. CEO Angelos Stergiou said the company continued advancing its clinical programs during the quarter while preparing...

(Editor’s note: This story and its headline have been updated to include the stock’s after-hours movement) Niagen Bioscience (NASDAQ:NAGE), whose anti-aging product counts longevity entrepreneur Bryan Johnson among its customers, reported its strongest financial results to date on...

CalciMedica, Inc. (NASDAQ:CALC) shares are down on Wednesday after the company announced the discontinuation of its Phase 2 KOURAGE clinical trial. The trial was evaluating Auxora in patients with Stage 2 or Stage 3 acute kidney injury (AKI) with associated acute hypoxemic respiratory failure...

The Food and Drug Administration’s top vaccine regulator is pushing new limits on how vaccines win approval. The tougher standards could cloud prospects for vaccine makers and rattle investors in major healthcare and biotech names. Center for Biologics Evaluation and Research Director Vinay...

SciSparc Ltd. (NASDAQ:SPRC) traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza III Ventures Inc. (TSXV:MIZA), a publicly traded firm on Canada's TSX Venture Exchange The Tel Aviv-based pharmaceutical company develops treatments for...

Biodexa Pharmaceuticals PLC-ADR (NASDAQ:BDRX) saw its stock fall 3.67% to $10.50 during after-hours trading on Thursday. Check out the current price of BDRX stock here. According to Benzinga Pro data, after closing the regular session at $10.90, up $3.19 or 41.37%, the stock of the biotech then...

Kala Bio Inc. (NASDAQ: KALA) stock is down on Monday after the company halted development of its experimental treatment for a specific eye condition. The company had a session volume of 14.04 million compared to the average volume of 216.47 thousand, according to data from Benzinga Pro. On Monday,...

Editor’s Note: This article has been updated to correct an earlier inaccuracy regarding the company’s stock trajectory. Nektar Therapeutics Inc. (NASDAQ:NKTR) on Thursday shared new data from its ongoing REZOLVE-AD Phase 2b study of rezpegaldesleukin, an IL-2 pathway agonist and...

Sanofi SA (NASDAQ:SNY) shared new data from the HS-OBTAIN phase 2a study, which shows that treatment with brivekimig led to clinically meaningful improvements in the primary endpoint of Hidradenitis Suppurativa Clinical Response (HiSCR50) in patients naïve to biologics with moderate-to-severe...

Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) stock is surging on Monday, with a session volume of 11.67 million compared to the average volume of 408.08 thousand as per data from Benzinga Pro. Monte Rosa announced a collaboration with Novartis AG (NYSE:NVS) to develop novel degraders for immune-...

On Monday, Palantir Technologies Inc. (NASDAQ:PLTR) co-founder Joe Lonsdale urged a tech-driven transformation of the Food and Drug Administration, warning that bureaucratic inertia is putting the U.S. behind China in the biotech race. What Happened: In a blog post, Lonsdale said the FDA's current...

Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) stock experienced a drop of 5.54% on Thursday, followed by a remarkable recovery of 14.29% in after-hours trading. What Happened: Sonnet BioTherapeutics’ stock fell by 5% during regular trading hours on Thursday. The drop was attributed to...

Changpeng Zhao, the founder of cryptocurrency exchange Binance (CRYPTO: BNB), said Tuesday that he made a personal donation of $10 million to support Ethereum (CRYPTO: ETH) co-founder Vitalik Buterin’s biotech initiative. What Happened: Zhao, known popularly as “CZ,” ...